Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133(+) DAOY medulloblastoma cells

✍ Scribed by Borhane Annabi; Jinane Doumit; Karine Plouffe; Carl Laflamme; Simon Lord-Dufour; Richard Béliveau

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 216 KB
• Volume: 49
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/mc.20645

✦ Synopsis

Abstract

Members of the low‐density lipoprotein receptor‐related protein (LRP) family are involved in metabolic stress and resistance phenotypes of cancer cells. New breakthroughs in brain cancer therapy have exploited that molecular signature and proved that efficient delivery of therapeutic agents involve LRP‐mediated mechanisms. We performed gene expression profiling of CD133, a cell surface cancer stem cell marker, and of LRP in response to in vitro nutrient deprivation. We found that CD133 was selectively induced in serum‐starved DAOY medulloblastoma cells but not in U87MG glioblastoma cells. Such CD133 induction was correlated to increases in LRP‐1 and LRP‐1b gene and protein expression. When a specific CD133(+) DAOY cell population was sorted from parental DAOY, we found increases in LRP‐5 and LRP‐8. Uptake of α~2~‐macroglobulin, a specific LRP‐1/1b ligand, was increased in serum‐starved parental DAOY cells but not in CD133(+) DAOY cells, and receptor‐associated protein (RAP), which binds to all cell surface LRPs, was able to compete for that uptake. Conversely, RAP binding was increased in serum‐starved parental DAOY but α~2~‐macroglobulin was unable to compete for such uptake. Strategies aiming at targeting cancer stem cell metabolic adaptative responses, such as that through LRP differential expression within the brain tissue microenvironmental niche, can now be envisioned. © 2010 Wiley‐Liss, Inc.